Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a heterogeneous disease that accounts for 10–15% of all breast cancer cases. Within TNBC, the treatment of basal B is the most challenging due to its highly invasive potential, and thus treatments to suppress metastasis formation in this subgroup are urgently...

Descripción completa

Detalles Bibliográficos
Autores principales: Skov, Natascha, Alves, Carla L., Ehmsen, Sidse, Ditzel, Henrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456092/
https://www.ncbi.nlm.nih.gov/pubmed/36077449
http://dx.doi.org/10.3390/ijms231710053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456092/
https://www.ncbi.nlm.nih.gov/pubmed/36077449
http://dx.doi.org/10.3390/ijms231710053

Ejemplares similares